GlassScriptPhysician profile
Gabriel Stephen Lensing
NPI 1861920423
$15,130.92
in general payments reported to CMS, 2019-2025
20 companies · $3,631 in 2025
The $3,631 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,834 · 2020: $242 · 2021: $2,008 · 2022: $391 · 2023: $575 · 2024: $4,450 · 2025: $3,631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,696 · Travel and Lodging: $1,695 · Food and Beverage: $1,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,695.75 |
| Travel and Lodging | $1,694.85 |
| Food and Beverage | $1,264.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zavation Medical Products, LLC | $5,695.75 | 2024-2025 | |
| Alon Medical Technology | $3,621.77 | 2019 | |
| Alphatec Spine, INC | $2,225.33 | 2024-2025 | Other - Miscellaneous |
| Zimmer Biomet Holdings, INC. | $1,696.47 | 2021 | |
| Nuvasive, INC. | $660.81 | 2021-2023 | |
| Depuy Synthes Sales INC. | $628.29 | 2020-2023 | Sentio |
| Medtronic, INC. | $142.41 | 2023 | Mazor X System |
| Amgen INC. | $103.68 | 2019 | |
| Medical Device Business Services, INC. | $91.49 | 2019 | |
| Stryker Corporation | $68.00 | 2022-2023 | Spinejack |
| Globus Medical, INC. | $29.78 | 2025 | Xlif |
| Bioventus LLC | $23.44 | 2025 | Xcell |
| Providence Medical Technology, INC. | $22.76 | 2025 | |
| Si-Bone, INC. | $20.57 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $20.22 | 2023 | Zilretta, Iovera, Exparel |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $19.89 | 2024 | |
| Smith+Nephew, INC. | $17.45 | 2024 | Pico 7 |
| Mimedx Group, INC. | $17.23 | 2025 | |
| Biomarin Pharmaceutical INC. | $16.82 | 2019 | |
| Spineology INC. | $8.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Lensing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.